Literature DB >> 9828987

Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.

A J Wearden1, R K Morriss, R Mullis, P L Strickland, D J Pearson, L Appleby, I T Campbell, J A Morris.   

Abstract

BACKGROUND: The Joint Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners (1996) recommended graded exercise and antidepressants for patients with chronic fatigue syndrome. We assessed efficacy and acceptability of these treatments.
METHOD: Six-month prospective randomised placebo and therapist contact time controlled trial with allocation to one of four treatment cells: exercise and 20 mg fluoxetine, exercise and placebo drug, appointments only and 20 mg fluoxetine, appointments and placebo drug. Drug treatment was double blind and patients were blind to assignment to exercise or appointments.
RESULTS: Ninety-six (71%) of 136 patients completed the trial. Patients were more likely to drop out of exercise than non-exercise treatment (P = 0.05). In an intention to treat analysis, exercise resulted in fewer patients with case level fatigue than appointments only at 26 weeks (12 (18%) v. 4 (6%) respectively P = 0.025) and improvement in functional work capacity at 12 (P = 0.005) and 26 weeks (P = 0.03). Fluoxetine had a significant effect on depression at week 12 only (P = 0.04). Exercise significantly improved health perception (P = 0.012) and fatigue (P = 0.028) at 28 weeks.
CONCLUSIONS: Graded exercise produced improvements in functional work capacity and fatigue, while fluoxetine improved depression only.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828987     DOI: 10.1192/bjp.172.6.485

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  45 in total

Review 1.  Chronic fatigue syndrome.

Authors:  S Reid; T Chalder; A Cleare; M Hotopf; S Wessely
Journal:  BMJ       Date:  2000-01-29

2.  Chronic fatigue.

Authors:  D L Stevens
Journal:  West J Med       Date:  2001-11

Review 3.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Interventions for the treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  A M Bagnall; P Whiting; R Richardson; A J Sowden
Journal:  Qual Saf Health Care       Date:  2002-09

5.  Specific treatment of residual fatigue in depressed patients.

Authors:  Humberto Marin; Matthew A Menza
Journal:  Psychiatry (Edgmont)       Date:  2004-09

Review 6.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 7.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

Review 8.  Exercise and the treatment of clinical depression in adults: recent findings and future directions.

Authors:  Alisha L Brosse; Erin S Sheets; Heather S Lett; James A Blumenthal
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

9.  Chronic fatigue and indicators of long-term employment disability in psychosomatic inpatients.

Authors:  Karin Tritt; Marius Nickel; Ferdinand Mitterlehner; Cerstin Nickel; Petra Forthuber; Peter Leiberich; Wolfhardt Rother; Thomas Loew
Journal:  Wien Klin Wochenschr       Date:  2004-03-31       Impact factor: 1.704

10.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.